Client programs using CHOMax follow platform-defined workflows and phase-appropriate practices across the development lifecycle.

YD BioMed expects to advance two lead ophthalmology programs utilizing its LSC Exosome platform, each supported by targeted regulatory and clinical milestones, which the timing of these milestones ...

As drug development becomes more complex, so do the demands for accurate, reproducible bioanalytical data to prove their safety and efficacy. Method validation ensures the reliability of ...

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of an advanced animal mRNA vaccine platform to accelerate the development ...

As stricter fuel regulations and pressures intensify for a solution to the rising greenhouse gas emissions, the maritime ...

The European Commission has set out its plans to pursue a circular economy for plastics in 2026, such as proposing a Circular ...

Marico partners IIT Tirupati to develop sustainable bioactives extraction for healthier edible oils: Our Bureau, Mumbai: Marico Limited, ...

Terephthalic aldehyde — a key organic chemical intermediate — has become increasingly vital across high-precision synthesis ...

Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted ...

The sheer growth of small biotechs and mid‑sized pharma companies entering the field has reshaped expectations of Contract Development and Manufacturing Organisations (CDMOs).

An international research team reveals new molecular mechanisms associated with pathogenic mutations in the protein ...

Our first biotech bi-weekly of 2026 is here with recent innovations in genomic drug discovery, organoid development and ADC ...